Goldman Sachs downgrades Suja Life to Neutral, slashes PT to $12 (SUJA:NASDAQ)

Goldman Sachs downgraded Suja Life (SUJA) to 'neutral' from 'buy', citing weaker Q3 results and lowered 2026 guidance. The stock fell 18.3% in premarket trading, with the price target cut to $12.

Original reporting
Published Nov 11, 2026, 1:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 11, 2026, 1:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Goldman Sachs downgrades Suja Life to Neutral, slashes PT to $12 (SUJA:NASDAQ) — source image
Decision brief

The 30-second read

$SUJABearishMed
01

Why it matters

For traders, the key is the combination of (1) a sell-side rating reset and (2) a guidance expectation reset, both of which can shift near-term positioning and implied growth assumptions.

02

Market read

A downgrade with a guidance-linked thesis is a near-term catalyst that can drive continued volatility and risk-off positioning in SUJA.

03

What to watch

Premarket reaction may over-discount the downgrade; traders should watch for any follow-up from management on the drivers of the fiscal 2026 guidance reduction and whether demand trends are improving.

Relevance 7/10Novelty 6/10Timing: premarket today after the downgrade and guidance cut were reported

Background

The piece frames SUJA’s premarket decline as a direct response to Goldman’s downgrade and PT cut tied to weaker Q3 performance and reduced fiscal 2026 guidance.

Company-level read

Ticker impact

$SUJABearishHigh confidence
Context

Goldman downgraded Suja Life to Neutral and cut its price target after weaker-than-expected Q3 results and lowered fiscal 2026 guidance.

Expected impact

Likely further selling or continued weakness as traders weigh the guidance reset and downgrade signal.

Evidence & confidence

The article ties the premarket drop to a specific analyst action (downgrade and PT cut) and to company-specific fundamentals (Q3 miss and lowered fiscal 2026 guidance).

Market effects

Could modestly pressure sentiment toward packaged food and beverage peers if investors generalize the growth slowdown theme.

No clear regional spillover beyond US small-cap consumer staples sentiment.

Limited, company-specific analyst action with no stated global macro linkage.

Counterpoint

The downgrade may be more about analyst expectations than a fundamental deterioration beyond the already-known Q3 miss, so the stock could stabilize if results were temporarily pressured.

Key entities

  • Suja Life

    US-listed packaged beverage company whose stock fell premarket after Goldman downgraded it and lowered fiscal 2026 expectations.

  • Goldman Sachs

    Issued the downgrade to Neutral and cut the price target, citing weaker Q3 results and lowered fiscal 2026 guidance.

Related articles

$SUJAMed

Suja Life Inc (SUJA) (Q3 2026) Earnings Call Highlights: Sales Beat, Margin Pressure

Suja Life Inc (SUJA) reported Q3 2026 net sales of $76.4M, up 3% YoY, beating expectations. Adjusted EBITDA rose to $10.5M, but gross margin fell to 43.9%. The company gained market share in natural healthy beverages and saw strong growth in club and convenience channels. However, it lowered full-year guidance due to grocery channel pressure and increased promotional spend. Management discussed channel shifts, promotional strategies, and category trends during the earnings call.

$SUJAMed

Suja Life: Q3 Earnings Snapshot

Suja Life Inc. (SUJA) reported a Q3 loss of $5.3M, or 22 cents per share, but adjusted earnings of 6 cents per share, beating estimates. Revenue was $76.4M. The company forecasts Q4 revenue of $83.7M-$86.7M and full-year revenue of $351M-$354M, according to Zacks Investment Research.

$SUJAMed

Suja Life Reports Third Quarter 2026 Financial Results

SUJA LIFE, INC. (SUJA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Suja Life Reports Third Quarter 2026 Financial Results Net sales increased 3.3% year-over-year to $76.4 million Updates fiscal year 2026 outlook OCEANSIDE, CA, November 10, 2026 – Suja Life, Inc. (NASDAQ: SUJA) (“Suja Life,” “Suja” or the “Company”), a leading better-for-you beve

Med

Suja Life’s Recent Volatility Masks A Longer Game In Functional Beverages

Suja Life's stock fell to $9 from $18 after lowering full-year guidance due to grocery channel weakness. Investors are exploring lawsuits, citing potential misleading information. Despite Q2 sales growth of 11.6% to $83.9M, sequential sales dropped 21%. The company remains optimistic about its long-term strategy in the functional beverage market, which is expected to reach $400B by 2034.

$SUJAMed

Suja Defies Grocery Slowdown With Double-Digit Sales Growth in Q2

Suja Life, Inc. (Nasdaq: SUJA) reported Q2 net sales up 11.6% year over year to $83.9 million, citing volume growth and improved distribution. Gross profit increased 9.9% to $39.2 million, or 46.7% of sales. The company raised its 2026 outlook to $360 to $369 million net sales from $326.6 million in 2025.

$SUJAMed

Suja Life Reports Second Quarter 2026 Financial Results

SUJA LIFE, INC. (SUJA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Suja Life Reports Second Quarter 2026 Financial Results Net sales increased 11.6% year-over-year to $83.9 million Updates fiscal year 2026 outlook OCEANSIDE, CA, August 4, 2026 – Suja Life, Inc. (NASDAQ: SUJA) (“Suja Life,” “Suja” or the “Company”), a leading better-for-you bever